Porous Baicalin-Fe(III) ICP@Propofol nanocomposites for enhanced anesthetic efficacy and reduced toxicity via neuroprotection and ultrasound assistance

Shuo Zhang , Lei Shi , Jiansheng He , Ji Xia , Shunlian Li , Rong Wang , Qingyan Ma , Mingting Zhu , Peng Tang , Hao Tian , Feiqian Wang , Mingxi Wan , Daocheng Wu , Wei Gao , Xiancang Ma , Feng Zhu

Asian Journal of Pharmaceutical Sciences ›› 2026, Vol. 21 ›› Issue (1) : 101117

PDF (5989KB)
Asian Journal of Pharmaceutical Sciences ›› 2026, Vol. 21 ›› Issue (1) :101117 DOI: 10.1016/j.ajps.2026.101117
Research Article
research-article
Porous Baicalin-Fe(III) ICP@Propofol nanocomposites for enhanced anesthetic efficacy and reduced toxicity via neuroprotection and ultrasound assistance
Author information +
History +
PDF (5989KB)

Abstract

To enhance the anesthetic efficacy of propofol while mitigating its systemic toxicity and irreversible developmental neurotoxicity, we developed a strategy leveraging the neuroprotective effects of baicalin in combination with propofol anesthesia via baicalin-based nanocomposites. High propofol-loaded porous Baicalin-Fe(III) infinite coordination polymer@propofol nanocomposites were synthesized, wherein baicalin coordinates with Fe3+ ions to form porous nanoparticles that encapsulate propofol within a core-shell structure. These nanocomposites exhibited an average diameter of 92.3 ± 10.2 nm and a pore volume of 0.322 cm3/g, achieving ultra-high propofol loading (∼62%) with no detectable leakage over 100 d, attributed to their large surface area and strong molecular interactions. When combined with focused ultrasound (FUS) and microbubbles, the effective dose (ED50) of propofol decreased from 10 to 4.3 mg/kg, doubling the duration of anesthesia and extending the therapeutic window by 200%. Importantly, the therapeutic index improved 1.66-fold while vital physiological parameters remained stable. Histological analyses revealed an 80% reduction in neuronal injury compared to free propofol, and behavioral tests demonstrated significant enhancements in motor and cognitive performance, alongside recovery from propofol-induced irreversible developmental neurotoxicity, indicating effective neuroprotection. Collectively, this baicalin-propofol nanocomposite, coupled with FUS-mediated delivery, represents a promising approach for safe and long-term anesthesia in clinical applications.

Keywords

Propofol / Baicalin / Infinite coordination polymer / Neuroprotection / Ultrasound

Cite this article

Download citation ▾
Shuo Zhang, Lei Shi, Jiansheng He, Ji Xia, Shunlian Li, Rong Wang, Qingyan Ma, Mingting Zhu, Peng Tang, Hao Tian, Feiqian Wang, Mingxi Wan, Daocheng Wu, Wei Gao, Xiancang Ma, Feng Zhu. Porous Baicalin-Fe(III) ICP@Propofol nanocomposites for enhanced anesthetic efficacy and reduced toxicity via neuroprotection and ultrasound assistance. Asian Journal of Pharmaceutical Sciences, 2026, 21 (1) : 101117 DOI:10.1016/j.ajps.2026.101117

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Walsh CT. Propofol: milk of amnesia. Cell 2022; 185(25): 4861.

[2]

Han RH, Huang HM, Han H, Chen H, Zeng F, Xie X, et al. Propofol postconditioning ameliorates hypoxia/reoxygenation induced H9c2 cell apoptosis and autophagy via upregulating forkhead transcription factors under hyperglycemia. Mil Med Res 2021; 8(1): 58.

[3]

Kotani Y, Pruna A, Turi S, Borghi G, Lee TC, Zangrillo A, et al. Propofol and survival: an updated meta-analysis of randomized clinical trials. Crit Care 2023; 27(1): 139.

[4]

Olutoye OA, Baker BW, Belfort MA, Olutoye OO. Food and Drug Administration warning on anesthesia and brain development: implications for obstetric and fetal surgery. Am J Obstet Gynecol 2018; 218(1): 98-102.

[5]

Zhang TY, Ji DF, Sun JY, Song JL, Nie LM, Sun N. NPAS4 suppresses propofol-induced neurotoxicity by inhibiting autophagy in hippocampal neuronal cells. Arch Biochem Biophys 2021; 711: 109018.

[6]

Tang F, Zhao LL, Yu Q, Liu TY, Gong HY, Liu ZY, et al. Upregulation of miR-215 attenuates propofol-induced apoptosis and oxidative stress in developing neurons by targeting LATS2. Mol Med 2020; 26(1): 38.

[7]

Li WW, Cheng LZ, Zou Z, Tian ML, Zhang H, Raya AD, et al. (R)-alpha-methylhistamine suppresses inhibitory neurotransmission in hippocampal CA1 pyramidal neurons counteracting propofol-induced amnesia in rats. CNS Neurosci Ther 2014; 20(9): 851-9.

[8]

Xing N, Xing F, Li YN, Li PL, Zhang JW, Wang DM, et al. Dexmedetomidine improves propofol-induced neuronal injury in rat hippocampus with the involvement of miR-34a and the PI3K/Akt signaling pathway. Life Sci 2020; 247: 117359.

[9]

Udrea AM, Gradisteanu Pircalabioru G, Boboc AA, Mares C, Dinache A, Mernea M, et al. Advanced bioinformatics tools in the pharmacokinetic profiles of natural and synthetic compounds with anti-diabetic activity. Biomolecules 2021; 11(11): 1692.

[10]

Ding XW, Sun X, Shen XF, Lu Y, Wang JQ, Sun ZR, et al. Propofol attenuates TNF- α-induced MMP-9 expression in human cerebral microvascular endothelial cells by inhibiting Ca2+/CAMK II/ERK/NF- κb signaling pathway . Acta Pharmacol Sin 2019; 40(10): 1303-13.

[11]

Chen W, Ju XZ, Lu Y, Ding XW, Miao CH, Chen JW. Propofol improved hypoxia-impaired integrity of blood-brain barrier via modulating the expression and phosphorylation of zonula occludens-1. CNS Neurosci Ther 2019; 25(6): 704-13.

[12]

Wang C, Wang S, Wu C, Lei L, Wang DX, Zhang Q. Physical and chemical compatibility of etomidate and propofol injectable emulsions. Pharmacology 2021; 106(11-12): 644-57.

[13]

Nilsson N, Nezvalova-Henriksen K, Tho I. Emulsion stability of different intravenous propofol formulations in simulated co-administration with remifentanil hydrochloride. Pharm Technol Hosp Pharm 2019; 4(2): 77-87.

[14]

Visvabharathy L, Xayarath B, Weinberg G, Shilling RA, Freitag NE. Propofol increases host susceptibility to microbial infection by reducing subpopulations of mature immune effector cells at sites of infection. PLoS One 2015; 10(9): e0138043.

[15]

Chaki T, Hirata N, Yoshikawa Y, Tachibana S, Tokinaga Y, Yamakage M. Lipid emulsion, but not propofol, induces skeletal muscle damage and lipid peroxidation. J Anesth 2019; 33(6): 628-35.

[16]

Li Y, Wang B, Zhang LL, He SF, Hu XW, Wong GTC, et al. Dexmedetomidine combined with general anesthesia provides similar intraoperative stress response reduction when compared with a combined general and epidural anesthetic technique. Anesth Analg 2016; 122(4): 1202-10.

[17]

Du YT, Li YW, Zhao BJ, Guo XY, Feng Y, Zuo MZ, et al. Long-term survival after combined epidural-general anesthesia or general anesthesia alone: follow-up of a randomized trial. Anesthesiology 2021; 135(2): 233-45.

[18]

Li YW, Li HJ, Li HJ, Zhao BJ, Guo XY, Feng Y, et al. Delirium in older patients after combined epidural-general anesthesia or general anesthesia for major surgery: a randomized trial. Anesthesiology 2021; 135(2): 218-32.

[19]

Sridharan K, Sivaramakrishnan G. Comparison of fentanyl, remifentanil, sufentanil and alfentanil in combination with propofol for general anesthesia: a systematic review and meta-analysis of randomized controlled trials. Curr Clin Pharmacol 2019; 14(2): 116-24.

[20]

Hassani Najafabadi A, Azodi-Deilami S, Abdouss M, Payravand H, Farzaneh S. Synthesis and evaluation of hydroponically alginate nanoparticles as novel carrier for intravenous delivery of propofol. J Mater Sci Mater Med 2015; 26(3): 145.

[21]

Zhang S, Wang YS, Zhu MT, Liu BY, Zhao WP, Zhang S, et al. Ultrasound combined blood-brain barrier targeting brain delivery of four-in-one molecular aggregates for the enhancement of anesthetic efficacy and toxicity reduction via propofol-etomidate synergistically inhibition GABA receptor. Aggregate 2024; 5(5): e573.

[22]

McMahon D, O’Reilly MA, Hynynen K. Therapeutic agent delivery across the blood-brain barrier using focused ultrasound. Annu Rev Biomed Eng 2021; 23(1): 89-113.

[23]

Zhao PX, Wu TT, Tian Y, You J, Cui XW. Recent advances of focused ultrasound induced blood-brain barrier opening for clinical applications of neurodegenerative diseases. Adv Drug Deliv Rev 2024; 209: 115323.

[24]

Curley CT, Stevens AD, Mathew AS, Stasiak K, Garrison WJ, Miller GW, et al. Immunomodulation of intracranial melanoma in response to blood-tumor barrier opening with focused ultrasound. Theranostics 2020; 10(19): 8821-33.

[25]

Shen YY, Hu MN, Li W, Chen YL, Xu YL, Sun LT, et al. Delivery of DNA octahedra enhanced by focused ultrasound with microbubbles for glioma therapy. J Control Rel 2022; 350: 158-74.

[26]

Moore-Palhares D, Dasgupta A, Saifuddin M, Anzola Pena ML, Prasla S, Ho L, et al. Radiation enhancement using focussed ultrasound-stimulated microbubbles for breast cancer: a phase 1 clinical trial. PLoS Med 2024; 21(5): e1004408.

[27]

Li YF, Zhang YF, Huang C, Jiang JM. Baicalin improves neurological outcomes in mice with ischemic stroke by inhibiting astrocyte activation and neuroinflammation. Int Immunopharmacol 2025; 149: 114186.

[28]

Yang JL, Jia ZX, Xiao ZG, Zhao J, Lu Y, Chu L, et al. Baicalin rescues cognitive dysfunction, mitigates neurodegeneration, and exerts anti-epileptic effects through activating TLR4/MYD88/Caspase-3 pathway in rats. Drug Des Devel Ther 2021; 20(15): 3163-80.

[29]

Liu ZSJ, Truong TTT, Bortolasci CC, Spolding B, Panizzutti B, Swinton C, et al. The potential of baicalin to enhance neuroprotection and mitochondrial function in a human neuronal cell model. Mol Psychiatry 2024; 29(8): 2487-95.

[30]

Zheng WX, He WQ, Zhang QR, Jia JX, Zhao S, Wu FJ, et al. Baicalin inhibits NLRP3 inflammasome activity via the AMPK signaling pathway to alleviate cerebral ischemia-reperfusion injury. Inflammation 2021; 44(5): 2091-105.

[31]

Zhang L, Miao CY, Wang ZX, Guan XL, Ma YC, Song JY, et al. Preparation and characterisation of baicalin magnesium and its protective effect in ulcerative colitis via gut microbiota-bile acid axis modulation. Phytomedicine 2024; 126: 155416.

[32]

Alnasraui AHF, Joe IH, Al-Musawi S. Design and synthesize of folate decorated Fe3O4@Au-DEX-CP nano formulation for targeted drug delivery in colorectal cancer therapy: in vitro and in vivo studies . J Drug Deliv Sci Technol 2023; 87: 104798.

[33]

Abdulwahid FS, Haider AJ, Al-Musawi S. Effect of laser parameter on Fe3O4 NPs formation by pulsed laser ablation in liquid . AIP Conf Proc 2023; 2769: 020039.

[34]

Haider AJ, Al-Kinani MA, Al-Musawi S. Preparation and characterization of gold coated super paramagnetic iron nanoparticle using pulsed laser ablation in liquid method. Key Eng Mater 2021; 886: 77-85.

[35]

Chen J, Escoffre JM, Romito O, Iazourene T, Presset A, Roy M, et al. Enhanced macromolecular substance extravasation through the blood-brain barrier via acoustic bubble-cell interactions. Ultrason Sonochem 2024; 103: 106768.

[36]

Zhu MT, Wu PY, Li Y, Zhang L, Zong YJ, Wan MX. Synergistic therapy for orthotopic gliomas via biomimetic nanosonosensitizer-mediated sonodynamic therapy and ferroptosis. Biomater Sci 2022; 10(14): 3911-23.

[37]

Laferrière-Langlois P, Morisson L, Jeffries S, Duclos C, Espitalier F, Richebé P. Depth of anesthesia and nociception monitoring: current state and vision for 2050. Anesth Analg 2024; 138(2): 295-307.

[38]

Roche D, Mahon P. Depth of anesthesia monitoring. Anesthesiol Clin 2021; 39(3): 477-92.

[39]

Brook K, Agarwala AV, Li F, Purdon PL. Depth of anesthesia monitoring: an argument for its use for patient safety. Curr Opin Anaesthesiol 2024; 37(6): 689-96.

[40]

Filimonova M, Saburova A, Shevchenko L, Makarchuk V, Shitova A, Soldatova O, et al. 1-isobutanoil-2-isopropylisothiourea phosphate, T1082: a safe and effective prevention of radiotherapy complications in oncology. Int J Mol Sci 2022; 23(5): 2697.

[41]

Li ZY, Xiao XY, Xue YL, Zhou HL, Huang CN, Zhu M, et al. Discovery of a novel class of benzoxazole derivatives as histamine H3 receptor ligands for the treatment of neuropathic pain. Bioorg Chem 2022; 127: 106039.

[42]

Mehta M, Allen-Gipson D, Mohapatra S, Kindy M, Limayem A. Study on the therapeutic index and synergistic effect of Chitosan-zinc oxide nanomicellar composites for drug-resistant bacterial biofilm inhibition. Int J Pharm 2019; 565: 472-80.

[43]

Xiong S, Li ZJ, Liu Y, Wang Q, Luo JS, Chen XJ, et al. Brain-targeted delivery shuttled by black phosphorus nanostructure to treat Parkinson’s disease. Biomaterials 2020; 260: 120339.

[44]

Li LJ, Sun XY, Huang YR, Lu S, Xu YM, Yang J, et al. Neuronal double-stranded DNA accumulation induced by DNase II deficiency drives tau phosphorylation and neurodegeneration. Transl Neurodegener 2024; 13(1): 1-17.

[45]

Liu XY, Zhao YC, Dou JB, Hou QH, Cheng JX, Jiang XY. Bioeffects of inhaled nanoplastics on neurons and alteration of animal behaviors through deposition in the brain. Nano Lett 2022; 22(3): 1091-9.

[46]

Sadegzadeh F, Sakhaie N, Dehghany R, Adak O, Saadati H. Effects of adolescent administration of fluoxetine on novel object recognition memory, anxiety-like behaviors, and hippocampal brain-derived neurotrophic factor level. Life Sci 2020; 260: 118338.

[47]

Farokhcheh M, Hejazian L, Akbarnejad Z, Pourabdolhossein F, Hosseini SM, Mehraei TM, et al. Geraniol improved memory impairment and neurotoxicity induced by zinc oxide nanoparticles in male Wistar rats through its antioxidant effect. Life Sci 2021; 282: 119823.

PDF (5989KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉